694 related articles for article (PubMed ID: 27002405)
1. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
2. Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway.
Qu Y; Zhang L; Kang Z; Jiang W; Lv C
Pulm Pharmacol Ther; 2015 Oct; 34():1-7. PubMed ID: 26254990
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
4. Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.
Zhang L; Ji YX; Jiang WL; Lv CJ
Braz J Med Biol Res; 2015 Jun; 48(6):545-52. PubMed ID: 25992646
[TBL] [Abstract][Full Text] [Related]
5. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
6. Ponatinib attenuates experimental pulmonary arterial hypertension by modulating Wnt signaling and vasohibin-2/vasohibin-1.
Kang Z; Ji Y; Zhang G; Qu Y; Zhang L; Jiang W
Life Sci; 2016 Mar; 148():1-8. PubMed ID: 26860892
[TBL] [Abstract][Full Text] [Related]
7. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
[TBL] [Abstract][Full Text] [Related]
8. Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.
Wang C; Song X; Li Y; Han F; Gao S; Wang X; Xie S; Lv C
PLoS One; 2013; 8(8):e70725. PubMed ID: 23967091
[TBL] [Abstract][Full Text] [Related]
9. Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.
Song S; Ji Y; Zhang G; Zhang X; Li B; Li D; Jiang W
Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):199-207. PubMed ID: 28816009
[TBL] [Abstract][Full Text] [Related]
10. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats.
Song X; Liu W; Xie S; Wang M; Cao G; Mao C; Lv C
Lab Invest; 2013 Nov; 93(11):1219-31. PubMed ID: 24042439
[TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
Gao L; Jiang D; Geng J; Dong R; Dai H
Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X
Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis.
Shimbori C; Bellaye PS; Xia J; Gauldie J; Ask K; Ramos C; Becerril C; Pardo A; Selman M; Kolb M
J Pathol; 2016 Oct; 240(2):197-210. PubMed ID: 27425145
[TBL] [Abstract][Full Text] [Related]
17. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
18. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
19. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
[TBL] [Abstract][Full Text] [Related]
20. Probucol ameliorates EMT and lung fibrosis through restoration of SIRT3 expression.
Zhang HX; Li YN; Wang XL; Ye CL; Zhu XY; Li HP; Yang T; Liu YJ
Pulm Pharmacol Ther; 2019 Aug; 57():101803. PubMed ID: 31085231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
